Duke University researchers have devised a promising, potent pain reliever — seemingly without the harmful side effects and ...

A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust ...

Duke scientists may have discovered a game-changing painkiller. SBI-810 is a new non-opioid drug that offers potent pain ...

Eli Lilly will buy privately held SiteOne Therapeutics in a deal worth as much as $1 billion, the companies said on Tuesday, giving the drugmaker access to an experimental non-opioid pain medicine.

a non-opioid treatment, takes a more focused approach, activating only a specific pain-relief pathway that avoids the euphoric "high" linked to addiction. In tests in mice, SBI-810 worked well on ...

Eli Lilly has reached a deal to acquire SiteOne Therapeutics that would give it control of a non-opioid pain drug that would ...

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...

While opioids flood multiple cellular pathways indiscriminately, SBI-810, a non-opioid treatment, takes a more focused approach, activating only a specific pain-relief pathway that avoids the ...

Vertex and Eli Lilly are revolutionizing non-opioid pain management with NaV1.8 advancements. See why I'm bullish about LLY ...

Final enrollment concludes for Spark Biomedical's pivotal study investigating a non-invasive, drug-free neurostimulation ...